company background image
37T logo

Forte Biosciences DB:37T Stock Report

Last Price

€6.80

Market Cap

€22.4m

7D

0%

1Y

-23.2%

Updated

24 Nov, 2024

Data

Company Financials +

37T Stock Overview

Operates as a biopharmaceutical company in the United States. More details

37T fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Forte Biosciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Forte Biosciences
Historical stock prices
Current Share PriceUS$6.80
52 Week HighUS$18.75
52 Week LowUS$6.05
Beta1.46
11 Month Change0%
3 Month Change7.09%
1 Year Change-23.16%
33 Year Change-88.76%
5 Year Changen/a
Change since IPO-98.14%

Recent News & Updates

Recent updates

Shareholder Returns

37TDE BiotechsDE Market
7D0%-0.7%-0.02%
1Y-23.2%-17.2%8.2%

Return vs Industry: 37T underperformed the German Biotechs industry which returned -17.2% over the past year.

Return vs Market: 37T underperformed the German Market which returned 8.2% over the past year.

Price Volatility

Is 37T's price volatile compared to industry and market?
37T volatility
37T Average Weekly Movementn/a
Biotechs Industry Average Movement6.4%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 37T's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 37T's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a11Paul A. Wagnerwww.fortebiorx.com

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Forte Biosciences, Inc. Fundamentals Summary

How do Forte Biosciences's earnings and revenue compare to its market cap?
37T fundamental statistics
Market cap€22.44m
Earnings (TTM)-€32.84m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
37T income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$34.20m
Earnings-US$34.19m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-23.42
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did 37T perform over the long term?

See historical performance and comparison